HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Apolipoproteins C (ApoC)

A group of apolipoproteins that can readily exchange among the various classes of lipoproteins (HDL; VLDL; CHYLOMICRONS). After lipolysis of TRIGLYCERIDES on VLDL and chylomicrons, Apo-C proteins are normally transferred to HDL. The subtypes can modulate remnant binding to receptors, LECITHIN CHOLESTEROL ACYLTRANSFERASE, or LIPOPROTEIN LIPASE.
Also Known As:
ApoC; Apo C; Apoprotein (C); Apoproteins C; Apo-C
Networked: 180 relevant articles (7 outcomes, 21 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sékétéli, A: 10 articles (02/2007 - 03/2002)
2. Noma, M: 10 articles (02/2007 - 03/2002)
3. Amazigo, Uche V: 8 articles (09/2015 - 02/2007)
4. Noma, Mounkaila: 6 articles (09/2015 - 01/2012)
5. Howlett, Geoffrey J: 6 articles (02/2011 - 03/2007)
6. Amazigo, U V: 6 articles (03/2002 - 03/2002)
7. Zouré, Honorat G M: 5 articles (09/2015 - 07/2012)
8. Wanji, Samuel: 5 articles (01/2015 - 02/2007)
9. Rensen, Patrick C N: 5 articles (01/2011 - 02/2005)
10. Berbée, Jimmy F P: 5 articles (01/2011 - 02/2005)

Related Diseases

1. Hypertriglyceridemia
2. Hyperlipidemias (Hyperlipidemia)
3. Obesity
4. Inflammation
11/01/2012 - "WAT apoC-I secretion over 4 hours correlated with fasting total and non-high-density lipoprotein apoC-I but not with high-density lipoprotein apoC-I and was the primary predictor of 4-hour postprandial increases in TRL apoC-I. Correction for TRL apoC-I eliminated the association of WAT apoC-I with 6-hour area under the curve of plasma (13)C-triglyceride; correction for insulin sensitivity or inflammation did not. "
09/01/2014 - "Plasma apoC-I, apoC-II, apoC-III, and apoE are not associated with adiposity, insulin sensitivity, or inflammation in obese but healthy postmenopausal women. "
09/01/2014 - "At baseline, there was no association between the plasma transferable apolipoproteins with any index of adiposity, insulin sensitivity, lipids, or inflammation, except for apoE with peripheral fat mass (r = 0.18, P < .05), and apoC-II and apoC-III with cholesterol (r = 0.23 and r = 0.20 respectively, P < .05). "
05/01/2010 - "Biological classification of proteins with significant changes revealed functions previously implicated in development of NASH in humans, including immune system regulation and inflammation (orosomucoid 1, serum amyloid P component, paraoxonase 1, protein similar to alpha-2-macroglobulin precursor, beta-2-microglobulin, p101 protein, and complement components 2 and C8G), lipid metabolism (apolipoproteins C-III, E, E precursor, B, and N), structural and extracellular matrix proteins (transthyretin and endopeptidase 24.16 type M2), and coagulation [carboxypeptidase B2 (plasma)]. "
5. Fatty Liver

Related Drugs and Biologics

1. Lipoproteins (Lipoprotein)
2. Cholesterol
3. Lipoprotein Lipase (Diacylglycerol Lipase)
4. Apolipoprotein C-II (ApoC2)
5. Apolipoprotein C-III
6. Apolipoproteins
7. Lipase (Acid Lipase)
8. Insulin (Novolin)
9. Pre-beta High-Density Lipoproteins
10. LDL-Receptor Related Protein 1 (LDL-Receptor Related Protein)

Related Therapies and Procedures

1. Cardiopulmonary Resuscitation (CPR)
2. Resuscitation
3. Drug Therapy (Chemotherapy)